JP2021073194A5 - - Google Patents

Download PDF

Info

Publication number
JP2021073194A5
JP2021073194A5 JP2020218615A JP2020218615A JP2021073194A5 JP 2021073194 A5 JP2021073194 A5 JP 2021073194A5 JP 2020218615 A JP2020218615 A JP 2020218615A JP 2020218615 A JP2020218615 A JP 2020218615A JP 2021073194 A5 JP2021073194 A5 JP 2021073194A5
Authority
JP
Japan
Prior art keywords
salt
composition
composition according
weight
hetre
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020218615A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021073194A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021073194A publication Critical patent/JP2021073194A/ja
Publication of JP2021073194A5 publication Critical patent/JP2021073194A5/ja
Pending legal-status Critical Current

Links

JP2020218615A 2013-11-15 2020-12-28 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩 Pending JP2021073194A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361904600P 2013-11-15 2013-11-15
US61/904,600 2013-11-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019212877A Division JP6818851B2 (ja) 2013-11-15 2019-11-26 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩

Publications (2)

Publication Number Publication Date
JP2021073194A JP2021073194A (ja) 2021-05-13
JP2021073194A5 true JP2021073194A5 (https=) 2021-11-25

Family

ID=52669635

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016530882A Pending JP2016538288A (ja) 2013-11-15 2014-11-17 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩
JP2019212877A Expired - Fee Related JP6818851B2 (ja) 2013-11-15 2019-11-26 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩
JP2020218615A Pending JP2021073194A (ja) 2013-11-15 2020-12-28 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016530882A Pending JP2016538288A (ja) 2013-11-15 2014-11-17 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩
JP2019212877A Expired - Fee Related JP6818851B2 (ja) 2013-11-15 2019-11-26 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩

Country Status (6)

Country Link
US (3) US10017453B2 (https=)
EP (3) EP3068757B1 (https=)
JP (3) JP2016538288A (https=)
CN (2) CN105899485B (https=)
ES (1) ES2727387T3 (https=)
WO (1) WO2015071766A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180094516A (ko) * 2015-12-18 2018-08-23 애피뮨 리미티드 15-hepe를 포함하는 조성물 및 이를 사용하는 방법
EP3597039B1 (en) * 2017-03-14 2024-05-01 Ibiden Co., Ltd. Plant activator
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
US20220133669A1 (en) 2020-10-30 2022-05-05 Ds Biopharma Limited Pharmaceutical compositions comprising 15-hetre and methods of use thereof
FR3148365A1 (fr) * 2023-05-04 2024-11-08 Pierre Fabre Dermo-Cosmetique Oxylipines dans le traitement de la séborrhée et/ou de l’acné

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3055923A (en) * 1960-03-25 1962-09-25 Baxter Laboratories Inc Fatty acid salts
IE47777B1 (en) 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
JPH04507397A (ja) 1988-01-14 1992-12-24 フリッツ，アンデルス 湿疹治療用薬剤製造における必須脂肪酸の使用法
GB9111900D0 (en) 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
JPH05186342A (ja) 1992-01-10 1993-07-27 Fujirebio Inc 免疫調節作用を併せもつ抗炎症剤
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
GB9301446D0 (en) 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage
AU683027B2 (en) 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
EA002520B1 (ru) * 1996-09-20 2002-06-27 Атеродженикс, Инк. Выделенное антитело и его фрагмент, способы и набор для оценки уровня перекисного окисления липидов в биологическом образце и способ диагностики заболеваний, обусловленных перекисным окислением липидов
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
JP2002515480A (ja) * 1998-05-15 2002-05-28 ユニバーシティ オブ バーモント １６−ヒドロキシエイコサテトラエン酸の新規アナログ
JP2000191525A (ja) 1998-12-25 2000-07-11 Nof Corp 皮膚外用剤組成物
CA2388044A1 (en) * 1999-11-09 2001-05-17 Alcon, Inc. Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders
JP4932116B2 (ja) 2000-02-16 2012-05-16 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド アスピリン誘発脂質メディエータ
US20020188024A1 (en) 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
DE10121252A1 (de) 2001-04-30 2002-11-07 Christos C Zouboulis Behandlung der Akne
WO2004072013A1 (ja) * 2003-02-14 2004-08-26 Taisho Pharmaceutical Co.,Ltd. ヒドロキシエイコサジエン酸化合物
JP2005179211A (ja) 2003-12-17 2005-07-07 Idemitsu Kosan Co Ltd 皮膚外用剤組成物
US20070105954A1 (en) 2003-12-31 2007-05-10 Ingennus Limited Formulation containing a carboxylic acid or an ester thereof
US20050239889A1 (en) 2004-04-26 2005-10-27 Jean Gosselin In vivo release of endogenous anti-microbial mediators by leukotriene B4 (LTB4) administration
US7666447B2 (en) 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
US7893106B2 (en) 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
WO2006085687A1 (ja) 2005-02-14 2006-08-17 Suntory Limited ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物
TW200711649A (en) 2005-06-17 2007-04-01 Combinatorx Inc Combination therapy for the treatment of immunoinflammatory disorders
BRPI0715402A2 (pt) 2006-08-08 2013-11-26 Lipomics Technologies Inc Marcadores de doença hepática gordurosa não alcoólica (nafld) e esteatohepatite não alcoólica (nash) e métodos de uso dos mesmos
JP5101894B2 (ja) 2007-01-15 2012-12-19 サントリーホールディングス株式会社 高度不飽和脂肪酸及びこれを含有する脂質の製造方法
GB0802116D0 (en) 2008-02-05 2008-03-12 Natural Enviromental Res Counc Treatment
WO2009154230A1 (ja) 2008-06-17 2009-12-23 持田製薬株式会社 非アルコール性脂肪肝炎の予防／改善・治療薬
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
GB0907601D0 (en) * 2009-05-01 2009-06-10 Equateq Ltd Novel methods
WO2012135032A2 (en) 2011-03-25 2012-10-04 The Brigham And Women's Hospital, Inc. Anti-inflammatory particles
US20120264824A1 (en) 2011-04-15 2012-10-18 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
SG11201401629XA (en) 2011-10-19 2014-05-29 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
SG11201402653QA (en) 2011-11-29 2014-06-27 Dignity Sciences Ltd Compositions comprising 20-carbon fatty acids and methods of making and using same
UA114615C2 (uk) 2012-01-06 2017-07-10 Омтера Фармасьютікалз, Інк. Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти
US20120264705A1 (en) * 2012-01-26 2012-10-18 Dignity Sciences Limited Antimicrobial compositions comprising 15-hetre and methods of use thereof
US20130267598A1 (en) 2012-02-23 2013-10-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same
EP2833740B1 (en) 2012-04-04 2016-09-14 Pronova BioPharma Norge AS Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
DK2858496T3 (da) 2012-05-10 2023-07-24 Solutex Na Llc Olier med anti-inflammatorisk aktivitet, som indeholder naturlige specialiserede pro-afhjælpningsmediatorer og deres forløbere
WO2014022816A2 (en) 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
SG10202000496XA (en) 2014-01-10 2020-03-30 Afimmune Ltd Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
ES2784240T3 (es) 2014-06-04 2020-09-23 Ds Biopharma Ltd Composiciones farmacéuticas que comprenden DGLA y uso de las mismas
MA41120A (fr) 2014-12-02 2017-10-10 Afimmune Ltd Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
KR20180094516A (ko) 2015-12-18 2018-08-23 애피뮨 리미티드 15-hepe를 포함하는 조성물 및 이를 사용하는 방법
EP3399971A1 (en) 2016-01-07 2018-11-14 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same

Similar Documents

Publication Publication Date Title
JP2021073194A5 (https=)
JP2019081783A5 (https=)
JP2689991B2 (ja) 組成物
JP5558113B2 (ja) 生理冷却剤を含む組成物
JP2024057010A5 (https=)
JP2017526738A5 (https=)
JP2019189650A5 (https=)
JP2008543854A (ja) 炎症状態を治療するための組成物および方法
WO2007102243A1 (ja) 外用の医薬組成物
JP2015508068A5 (https=)
JP2017222722A5 (https=)
JP2016532654A5 (https=)
TW201703759A (zh) 調味劑及含有該調味劑的口腔用組合物
JP2009544665A5 (https=)
JP2015504860A5 (https=)
JP2003342131A (ja) 頭皮治療剤組成物
JP2023041793A5 (https=)
JP2011529936A5 (https=)
HRP20161594T1 (hr) Pripravci za liječenje rozaceje koji sadrže kitozan i amid dikarboksilne kiseline
RU2006137282A (ru) Химически устойчивые композиции 4-гидрокси-тамоксифена
JP6598744B2 (ja) 歯磨き剤組成物
HRP20230641T1 (hr) Pripravak za topikalnu uporabu na bazi karnozin-magnezij kompleksa
JPWO2023286780A5 (https=)
JP2018515575A (ja) 浸透圧保護剤としてのリポ酸およびタウリンの組み合わせ
JP2012006962A (ja) 眼科用組成物